These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 15741178

  • 41. Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides.
    Hang JQ, Rajendran S, Yang Y, Li Y, In PW, Overton H, Parkes KE, Cammack N, Martin JA, Klumpp K.
    Biochem Biophys Res Commun; 2004 Apr 30; 317(2):321-9. PubMed ID: 15063760
    [Abstract] [Full Text] [Related]

  • 42. Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold.
    Williams PD, Staas DD, Venkatraman S, Loughran HM, Ruzek RD, Booth TM, Lyle TA, Wai JS, Vacca JP, Feuston BP, Ecto LT, Flynn JA, DiStefano DJ, Hazuda DJ, Bahnck CM, Himmelberger AL, Dornadula G, Hrin RC, Stillmock KA, Witmer MV, Miller MD, Grobler JA.
    Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6754-7. PubMed ID: 20869872
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site.
    Himmel DM, Maegley KA, Pauly TA, Bauman JD, Das K, Dharia C, Clark AD, Ryan K, Hickey MJ, Love RA, Hughes SH, Bergqvist S, Arnold E.
    Structure; 2009 Dec 09; 17(12):1625-1635. PubMed ID: 20004166
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.
    Kirschberg TA, Balakrishnan M, Squires NH, Barnes T, Brendza KM, Chen X, Eisenberg EJ, Jin W, Kutty N, Leavitt S, Liclican A, Liu Q, Liu X, Mak J, Perry JK, Wang M, Watkins WJ, Lansdon EB.
    J Med Chem; 2009 Oct 08; 52(19):5781-4. PubMed ID: 19791799
    [Abstract] [Full Text] [Related]

  • 52. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
    Hatta T, Takai K, Yokoyama S, Nakashima H, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 1995 Jun 26; 211(3):1041-6. PubMed ID: 7541196
    [Abstract] [Full Text] [Related]

  • 53. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A, Onnis V, Deplano A, Bianco G, Demurtas M, Distinto S, Cheng YC, Alcaro S, Esposito F, Tramontano E.
    Pathog Dis; 2017 Aug 31; 75(6):. PubMed ID: 28859311
    [Abstract] [Full Text] [Related]

  • 54. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A, Meleddu R, Esposito F, Distinto S, Bianco G, Masaoka T, Maccioni E, Menéndez-Arias L, Alcaro S, Le Grice SF, Tramontano E.
    PLoS One; 2016 Aug 31; 11(1):e0147225. PubMed ID: 26800261
    [Abstract] [Full Text] [Related]

  • 55. Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients.
    Roquebert B, Wirden M, Simon A, Deval J, Katlama C, Calvez V, Marcelin AG.
    J Med Virol; 2007 Mar 31; 79(3):207-11. PubMed ID: 17245724
    [Abstract] [Full Text] [Related]

  • 56. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
    Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A.
    Arch Biochem Biophys; 2007 Feb 15; 458(2):202-12. PubMed ID: 17257575
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase.
    Bessong PO, Obi CL, Andréola ML, Rojas LB, Pouységu L, Igumbor E, Meyer JJ, Quideau S, Litvak S.
    J Ethnopharmacol; 2005 May 13; 99(1):83-91. PubMed ID: 15848024
    [Abstract] [Full Text] [Related]

  • 59. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
    Menéndez-Arias L.
    Virus Res; 2008 Jun 13; 134(1-2):124-46. PubMed ID: 18272247
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.